Autoimmune channelopathies: Well-established and emerging immunotherapy-responsive diseases of the peripheral and central nervous systems

Journal of Clinical Immunology

Volumn 30, Issue SUPPL. 1, 2010, Pages

  Vincent, Angela ^a  

^a NONE

Author keywords

Autoimmune channelopathies; Encephalitis; Encephalopathies; Immunotherapies; Lambert Eaton myasthenic syndrome; Myasthenia gravis

Indexed keywords

ANTIBODY; AQUAPOTIN 4 ANTIBODY; CARBAMAZEPINE; CHOLINERGIC RECEPTOR ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; GLYCINE RECEPTOR ANTIBODY; IMMUNOGLOBULIN; MUSCLE SPECIFIC KINASE ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; PHENYTOIN; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL ANTIBODY; VOLTAGE GATED POTASSIUM CHANNEL ANTIBODY; AQP4 PROTEIN, HUMAN; AQUAPORIN 4; AUTOANTIBODY; AUTOANTIGEN; CALCIUM CHANNEL; CORTICOSTEROID; GLUTAMATE DECARBOXYLASE; NEUROTRANSMITTER RECEPTOR; VOLTAGE GATED POTASSIUM CHANNEL;

ANTIBODY DETECTION; ANTIGEN BINDING; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CHANNELOPATHY; DEVELOPMENTAL DISORDER; DISEASE ACTIVITY; DISEASE SEVERITY; EATON LAMBERT SYNDROME; ENCEPHALITIS; EPILEPSY; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; MORVAN SYNDROME; MYASTHENIA GRAVIS; MYELOOPTIC NEUROPATHY; MYOKYMIA; NEUROLOGIC DISEASE; NONHUMAN; PARANEOPLASTIC NEUROPATHY; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION; REVIEW; SENSITIVITY AND SPECIFICITY; ADULT; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CHANNELOPATHIES; IMMUNOLOGY; IMMUNOTHERAPY; MYASTHENIC SYNDROMES, CONGENITAL; NEWBORN; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM;

ADRENAL CORTEX HORMONES; ADULT; AQUAPORIN 4; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CALCIUM CHANNELS; CHANNELOPATHIES; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOTHERAPY; INFANT, NEWBORN; MYASTHENIC SYNDROMES, CONGENITAL; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PLASMA EXCHANGE; POTASSIUM CHANNELS, VOLTAGE-GATED; RECEPTORS, NEUROTRANSMITTER;

EID: 77956191392     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9401-x     Document Type: Review

References (46)

1. Vincent A, Lang B, Kleopa KA. Autoimmune channelopathies and related neurological disorders. Neuron. 2006;52:123-138
2. Newsom-Davis J, Pinching AJ, Vincent A, Wilson SG. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology. 1978;28:266-272
3. Toyka KV, Brachman DB, Pestronk A, Kao I. Myasthenia gravis: passive transfer from man to mouse. Science. 1975;190:397-399
4. Toyka KV, Drachman DB, Griffin DE, Pestronk A, Winkelstein JA, Fishbeck KH, et al. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med. 1977;296:125-131
5. Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol. 2002;2:797-804.
6. Willcox N, Leite MI, Kadota Y, JonesM, Meager A, Subrahmanyam P, et al. Autoimmunizing mechanisms in thymoma and thymus. Ann NYAcad Sci. 2008;1132:163-173
7. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med. 2001;7:365-368
8. Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, et al. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain. 2008;131:1940-1952 (Pubitemid 351957451)
9. Vincent A, Newland C, Brueton L, Beeson D, Riemersma S, Huson SM, et al. Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet. 1995;346:24-25
10. Polizzi A, Huson SM, Vincent A. Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis. Teratology. 2000;62:332-341
11. Jacobson L, Polizzi A, Morriss-Kay G, Vincent A. Plasma from human mothers of fetuses with severe arthrogryposis multiplex congenita causes deformities in mice. J Clin Invest. 1999;103:1031-1038
12. Dalton P, Deacon R, Blamire A, Pike M, McKinlay I, Stein J, et al. Maternal neuronal antibodies associated with autism and a language disorder. Ann Neurol. 2003;53:533-537
13. Lang B, Pinto A, Giovannini F, Newsom-Davis J, Vincent A. Pathogenic autoantibodies in the Lambert-Eaton myasthenic syndrome. Ann NY Acad Sci. 2003;998:187-195 (Pubitemid 37194158)
14. Bain PG, Motomura M, Newsom-Davis J, Misbah SA, Chapel HM, Lee ML, et al. Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Neurology. 1996;47:678-683
15. Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain. 2002;125:1887-1895
16. Sinha S, Newsom-Davis J, Mills K, Byrne N, Lang B, Vincent A. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome). Lancet. 1991;338:75-77
17. Shillito P, Molenaar PC, Vincent A, Leys K, Zheng W, van den Berg RJ, et al. Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol. 1995;38:714-722
18. Arimura K, Sonoda Y, Watanabe O, Nagado T, Kurono A, Tomimitsu H, et al. Isaacs' syndrome as a potassium channelopathy of the nerve. Muscle Nerve. 2002;(Suppl 11):55-58.
19. Maddison P, Lawn N, Mills KR, Vincent A, Donaghy M. Acquired neuromyotonia in a patient with spinal epidural abscess. Muscle Nerve. 1998;21:672-674
20. Turner MR, Madkhana A, Ebers GC, Clover L, Vincent A, McGavin G, et al. Wasp sting induced autoimmune neuromyotonia. J Neurol Neurosurg Psychiatry. 2006;77:704-705
21. Hart IK, Waters C, Vincent A, Newland C, Beeson D, Pongs O, et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol. 1997;41:238-246
22. Liguori R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P, et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain. 2001;124:2417-2426
23. Spinazzi M, Argentiero V, Zuliani L, Palmieri A, Tavolato B, Vincent A. Immunotherapy-reversed compulsive, monoaminergic, circadian rhythm disorder in Morvan syndrome. Neurology. 2008;71:2008-2010
24. Josephs KA, Silber MH, Fealey RD, Nippoldt TB, Auger RG, Vernino S. Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol. 2004;21:440-445
25. Buckley C, Oger J, Clover L, Tuzun E, Carpenter K, Jackson M, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol. 2001;50:73-78
26. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127:701-712
27. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology. 2004;62:1177-1182
28. Majoie HJ, de Baets M, Renier W, Lang B, Vincent A. Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res. 2006;71:135-141
29. McKnight K, Jiang Y, Hart Y, Cavey A, Wroe S, Blank M, et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurology. 2005;65:1730-1736
30. Irani SR, Buckley C, Vincent A, Cockerell OC, Rudge P, Johnson MR, et al. Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology. 2008;71:1647-1648
31. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106-2112 (Pubitemid 39626806)
32. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202:473-477
33. Waters P, Jarius S, Littleton E, Leite MI, Jacob S, Gray B, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol. 2008;65:913-919
34. Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain. 2008;131:3072-3080
35. Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, et al. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol. 2008;4:202-214
36. Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology. 2007;69:2221-2231
37. Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL, et al. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med. 2008;205:2473-2481
38. Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol. 2009;66(5):630-643
39. Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol. 2009;66(5):617-629
40. Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, et al. Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun. 2009;386 (4):623-627
41. Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC. Intra-cerebral injection of patient immunoglobulin and human complement produce neuromyelitis optica lesions in mice. Brain. 2010;133:349-361
42. Hutchinson M, Waters P, McHugh J, Gorman G, O'Riordan S, Connolly S, et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology. 2008;71:1291-1292
43. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25-36. (Pubitemid 46214241)
44. Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008;7:327-340
45. Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66(1):11-18
46. Dale RC, Irani SR, Brilot F, Pillai S, Webster R, Gill D, et al. Nmethyl- D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol. 2009;66(5):704-709